Pia Järvenpää
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pia Järvenpää has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Perttu Arkkila
Department of Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4 shared publicationsLeena-Maija Aaltonen
Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, P.O. Box 263, 00029, Helsinki, Finland
3 shared publications- Ahmed Geneid
Department of Otorhinolaryngology and Phoniatrics-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
2 shared publications - Leena-Maija Aaltonen
Department of Otorhinolaryngology – Head and Neck Surgery Helsinki University Hospital and University of Helsinki Helsinki Finland
2 shared publications Mari Markkanen-Leppänen
Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, P.O. Box 263, FI-00029, Finland
2 shared publications- Petra Pietarinen
Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, P.O. Box 263, FI-00029, Finland
2 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (6)
Presence of Human Papillomaviruses in the Normal‐Appearing Hypopharyngeal Mucosa: A Prospective Study
Objective: Human papillomavirus (HPV) is a well‐established etiological factor in oropharyngeal cancer, whereas its role in the hypopharynx is less well understood. This prospective study investigated the prevalence of HPV in normal‐appearing hypopharyngeal mucosa using polymerase chain reaction (PCR)‐based HPV detection. Methods: Consecutive patients undergoing hypopharyngoscopy, laryngomicroscopy, or transnasal esophagogastroscopy for benign indications were prospectively recruited. Biopsies were obtained from normal‐appearing hypopharyngeal mucosa and analyzed for HPV DNA by PCR‐based genotyping. Participants completed a questionnaire addressing HPV‐related risk factors. Results: Tissue samples were collected from 53 patients (median age, 51 years; range, 18–85 years), of whom 32 (60.4%) were female. One sample was excluded because of insufficient DNA quality. Among the remaining 52 evaluable samples, one was positive for a cutaneous HPV type and one for high‐risk HPV18. The HPV18‐positive sample originated from a patient who was subsequently diagnosed with a p16‐positive squamous cell carcinoma arising in a vallecular cyst. RNA in situ hybridization confirmed transcriptionally active HPV within the tumor. A history of HPV‐associated benign disease was reported by 18 of 53 patients (34%). Conclusion: HPV DNA detection was rare in normal‐appearing hypopharyngeal mucosa, even among individuals with a history of HPV‐associated benign disease. Nevertheless, high‐risk HPV18 was detected in the hypopharyngeal mucosa of a patient with an HPV‐positive vallecular squamous cell carcinoma. These findings provide novel data on HPV prevalence in the hypopharynx and suggest that oncogenic HPV may occasionally be present in clinically normal hypopharyngeal mucosa. Level of Evidence: 4
- 9 November 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (6)
Open AccessPresence of Human Papillomaviruses in the Normal‐Appearing Hypopharyngeal Mucosa: A Prospective Study
Objective: Human papillomavirus (HPV) is a well‐established etiological factor in oropharyngeal cancer, whereas its role in the hypopharynx is less well understood. This prospective study investigated the prevalence of HPV in normal‐appearing hypopharyngeal mucosa using polymerase chain reaction (PCR)‐based HPV detection. Methods: Consecutive patients undergoing hypopharyngoscopy, laryngomicroscopy, or transnasal esophagogastroscopy for benign indications were prospectively recruited. Biopsies were obtained from normal‐appearing hypopharyngeal mucosa and analyzed for HPV DNA by PCR‐based genotyping. Participants completed a questionnaire addressing HPV‐related risk factors. Results: Tissue samples were collected from 53 patients (median age, 51 years; range, 18–85 years), of whom 32 (60.4%) were female. One sample was excluded because of insufficient DNA quality. Among the remaining 52 evaluable samples, one was positive for a cutaneous HPV type and one for high‐risk HPV18. The HPV18‐positive sample originated from a patient who was subsequently diagnosed with a p16‐positive squamous cell carcinoma arising in a vallecular cyst. RNA in situ hybridization confirmed transcriptionally active HPV within the tumor. A history of HPV‐associated benign disease was reported by 18 of 53 patients (34%). Conclusion: HPV DNA detection was rare in normal‐appearing hypopharyngeal mucosa, even among individuals with a history of HPV‐associated benign disease. Nevertheless, high‐risk HPV18 was detected in the hypopharyngeal mucosa of a patient with an HPV‐positive vallecular squamous cell carcinoma. These findings provide novel data on HPV prevalence in the hypopharynx and suggest that oncogenic HPV may occasionally be present in clinically normal hypopharyngeal mucosa. Level of Evidence: 4
- Open Access
- 23 March 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (2) , e1223
Efficient management of benign laryngeal symptoms in an endoscopy outpatient clinic
Objectives: A globus and thick mucus in the throat are common reasons for referral to an ear, nose, and throat (ENT) specialist. ENT outpatient appointments focus on nasolaryngoscopy examinations, patient education, and reassurance. An endoscopic outpatient clinic (EOC) was established to efficiently manage patients with benign laryngeal symptoms.Methods: Patients referred between February 2022 and June 2023 due to a globus and/or thick mucus in the throat were immediately contacted via post. The contact letter included patient education about the potential underlying reasons for their symptoms and self‐care instructions. A 15‐min outpatient visit was scheduled for an ENT examination and nasolaryngoscopy. Patients completed a questionnaire about their current symptoms and whether they had followed the self‐care instructions just before visiting the EOC and 1‐month following their appointment.Results: In total, 203 patients examined in the EOC were included in the study. Before the EOC visit, most patients (89.2%) considered the information letter useful, it relieved concerns in 44.2% of patients, and 73.2% patients had already followed the self‐care instructions. After the 1‐month follow‐up period, symptoms diminished significantly (p < .001).Conclusions: Instructions for self‐care and encouragement relieved concerns among patients with benign laryngeal symptoms. Moreover, symptoms improved significantly after a 1‐month follow‐up period.Level of evidence: 4.
- 23 March 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (2) , e1223
Open AccessEfficient management of benign laryngeal symptoms in an endoscopy outpatient clinic
Objectives: A globus and thick mucus in the throat are common reasons for referral to an ear, nose, and throat (ENT) specialist. ENT outpatient appointments focus on nasolaryngoscopy examinations, patient education, and reassurance. An endoscopic outpatient clinic (EOC) was established to efficiently manage patients with benign laryngeal symptoms.Methods: Patients referred between February 2022 and June 2023 due to a globus and/or thick mucus in the throat were immediately contacted via post. The contact letter included patient education about the potential underlying reasons for their symptoms and self‐care instructions. A 15‐min outpatient visit was scheduled for an ENT examination and nasolaryngoscopy. Patients completed a questionnaire about their current symptoms and whether they had followed the self‐care instructions just before visiting the EOC and 1‐month following their appointment.Results: In total, 203 patients examined in the EOC were included in the study. Before the EOC visit, most patients (89.2%) considered the information letter useful, it relieved concerns in 44.2% of patients, and 73.2% patients had already followed the self‐care instructions. After the 1‐month follow‐up period, symptoms diminished significantly (p < .001).Conclusions: Instructions for self‐care and encouragement relieved concerns among patients with benign laryngeal symptoms. Moreover, symptoms improved significantly after a 1‐month follow‐up period.Level of evidence: 4.
- Open Access
- 13 September 2021
- Published by Springer Nature in Dysphagia
- Vol. 37 (4) , 995-1007
Finnish Version of the Eating Assessment Tool (F-EAT-10): A Valid and Reliable Patient-reported Outcome Measure for Dysphagia Evaluation
Our aim was to validate a Finnish version of the Eating Assessment Tool (F-EAT-10) for clinical use and to test its reliability and validity in a multicenter nationwide study. Normative data were acquired from 180 non-dysphagic participants (median age 57.0 years, 62.2% female). Dysphagia patients (n = 117, median age 69.7 years, 53.0% female) referred to fiberoptic endoscopic evaluation of swallowing (FEES) completed F-EAT-10 before the examination and after 2 weeks. Patients underwent the 100-ml water swallow test (WST) and FEES was evaluated using the following three scales: the Yale Pharyngeal Residue Severity Rating Scale, Penetration-Aspiration Scale, and the Dysphagia Outcome Severity Scale. An operative cohort of 19 patients (median age 75.8 years, 57.9% female) underwent an endoscopic operation on Zenker’s diverticulum, tight cricopharyngeal muscle diagnosed in videofluorography, or both. Patients completed the F-EAT-10 preoperatively and 3 months postoperatively. The cut-off score for controls was < 3 (sensitivity 94.0%, specificity 96.1%) suggesting that ≥ 3 is abnormal. Re-questionnaires for test–retest reliability analysis were available from 92 FEES patients and 123 controls. The intraclass correlation coefficient was excellent for the total F-EAT-10 score (0.93, 95% confidence interval 0.91–0.95). Pearson correlation coefficients were strong (p < 0.001) for each of the questions and the total score. Internal consistency as assessed by Cronbach’s alpha was excellent (0.95). Some correlations between findings in FEES and 100-ml WST with F-EAT-10 were observed. The change in subjective symptoms of operative patients paralleled the change in F-EAT-10. F-EAT-10 is a reliable, valid, and symptom-specific patient-reported outcome measure for assessing dysphagia among Finnish speakers.
- 13 September 2021
- Published by Springer Nature in Dysphagia
- Vol. 37 (4) , 995-1007
Open AccessFinnish Version of the Eating Assessment Tool (F-EAT-10): A Valid and Reliable Patient-reported Outcome Measure for Dysphagia Evaluation
Our aim was to validate a Finnish version of the Eating Assessment Tool (F-EAT-10) for clinical use and to test its reliability and validity in a multicenter nationwide study. Normative data were acquired from 180 non-dysphagic participants (median age 57.0 years, 62.2% female). Dysphagia patients (n = 117, median age 69.7 years, 53.0% female) referred to fiberoptic endoscopic evaluation of swallowing (FEES) completed F-EAT-10 before the examination and after 2 weeks. Patients underwent the 100-ml water swallow test (WST) and FEES was evaluated using the following three scales: the Yale Pharyngeal Residue Severity Rating Scale, Penetration-Aspiration Scale, and the Dysphagia Outcome Severity Scale. An operative cohort of 19 patients (median age 75.8 years, 57.9% female) underwent an endoscopic operation on Zenker’s diverticulum, tight cricopharyngeal muscle diagnosed in videofluorography, or both. Patients completed the F-EAT-10 preoperatively and 3 months postoperatively. The cut-off score for controls was < 3 (sensitivity 94.0%, specificity 96.1%) suggesting that ≥ 3 is abnormal. Re-questionnaires for test–retest reliability analysis were available from 92 FEES patients and 123 controls. The intraclass correlation coefficient was excellent for the total F-EAT-10 score (0.93, 95% confidence interval 0.91–0.95). Pearson correlation coefficients were strong (p < 0.001) for each of the questions and the total score. Internal consistency as assessed by Cronbach’s alpha was excellent (0.95). Some correlations between findings in FEES and 100-ml WST with F-EAT-10 were observed. The change in subjective symptoms of operative patients paralleled the change in F-EAT-10. F-EAT-10 is a reliable, valid, and symptom-specific patient-reported outcome measure for assessing dysphagia among Finnish speakers.
- 21 September 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (12) , 3095-3096
Authors’ response to Commentary on “Role of barium swallow pharyngoesophagography in the management of globus pharyngeus”
- 21 September 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (12) , 3095-3096
Authors’ response to Commentary on “Role of barium swallow pharyngoesophagography in the management of globus pharyngeus”
- 25 June 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (8) , 1945-1953
Globus pharyngeus: a review of etiology, diagnostics, and treatment
Globus is a non-painful sensation of a lump or a foreign body in the throat, and it frequently improves with eating. Although globus is a common symptom, only little is known about the etiology, and the causes have remained controversial. Previously, globus was labelled as a hysterical symptom. However, nowadays, the research has been mainly focused on somatic causes and it is suspected that the etiology is complex. Because of the unclear etiology, the diagnostics and treatment are varying, predisposing patients to possible unnecessary investigations. This review presents the current literature of globus: its etiology, diagnostics, and treatment. In addition, a special aim is to discuss the rational investigation methods in globus diagnostics and present a diagnostic algorithm based on recent researches.
- 25 June 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (8) , 1945-1953
Globus pharyngeus: a review of etiology, diagnostics, and treatment
Globus is a non-painful sensation of a lump or a foreign body in the throat, and it frequently improves with eating. Although globus is a common symptom, only little is known about the etiology, and the causes have remained controversial. Previously, globus was labelled as a hysterical symptom. However, nowadays, the research has been mainly focused on somatic causes and it is suspected that the etiology is complex. Because of the unclear etiology, the diagnostics and treatment are varying, predisposing patients to possible unnecessary investigations. This review presents the current literature of globus: its etiology, diagnostics, and treatment. In addition, a special aim is to discuss the rational investigation methods in globus diagnostics and present a diagnostic algorithm based on recent researches.
- 9 November 2017
- Published by Taylor & Francis in Logopedics Phoniatrics Vocology
- Vol. 44 (2) , 67-72
Symptom relief and health-related quality of life in globus patients: a prospective study
Globus may be a persistent symptom impairing patients’ quality of life. Diagnostics and treatment are controversial but some globus patients may benefit from reassurance and attention. We investigated how globus symptoms change during a short-term follow-up without any treatment after an examination by an ear, nose and throat (ENT) physician and further diagnostic procedures. We also surveyed whether patients with persistent globus suffer from simultaneous voice problems. The study comprised 30 consecutive globus patients referred to Helsinki University Hospital, Department of Otorhinolaryngology – Head and Neck Surgery. We performed an ENT examination and scored patients’ videolaryngostroboscopies using the Reflux Finding Score (RFS). Patients filled in three questionnaires: the Reflux Symptom Index (RSI), the Deglutition Handicap Index (DHI) and the 15-Dimensional Measure of Health-Related Quality of Life (15-D HRQoL). Patients underwent transnasal esophagoscopy, high-resolution manometry, and 24-hour multichannel intraluminal impedance and pH monitoring. After a four-month follow-up, patients re-answered the same questionnaires and a speech and language pathologist (SLP) examined the patients. Baseline and follow-up questionnaires were available from 27 (90%) patients. According to the RSI (p = .001) and the DHI (p = .003), patients’ symptoms diminished after four months. The 15-D showed improvement in one subscale measuring discomfort and symptoms (p = .023). The SLP examined 23 (77%) patients, finding functional voice problems in six (26%). The study showed that most globus patients felt their symptoms diminished without any treatment during four months. In some patients, coexisting voice problems may be associated with persistent globus.
- 9 November 2017
- Published by Taylor & Francis in Logopedics Phoniatrics Vocology
- Vol. 44 (2) , 67-72
Symptom relief and health-related quality of life in globus patients: a prospective study
Globus may be a persistent symptom impairing patients’ quality of life. Diagnostics and treatment are controversial but some globus patients may benefit from reassurance and attention. We investigated how globus symptoms change during a short-term follow-up without any treatment after an examination by an ear, nose and throat (ENT) physician and further diagnostic procedures. We also surveyed whether patients with persistent globus suffer from simultaneous voice problems. The study comprised 30 consecutive globus patients referred to Helsinki University Hospital, Department of Otorhinolaryngology – Head and Neck Surgery. We performed an ENT examination and scored patients’ videolaryngostroboscopies using the Reflux Finding Score (RFS). Patients filled in three questionnaires: the Reflux Symptom Index (RSI), the Deglutition Handicap Index (DHI) and the 15-Dimensional Measure of Health-Related Quality of Life (15-D HRQoL). Patients underwent transnasal esophagoscopy, high-resolution manometry, and 24-hour multichannel intraluminal impedance and pH monitoring. After a four-month follow-up, patients re-answered the same questionnaires and a speech and language pathologist (SLP) examined the patients. Baseline and follow-up questionnaires were available from 27 (90%) patients. According to the RSI (p = .001) and the DHI (p = .003), patients’ symptoms diminished after four months. The 15-D showed improvement in one subscale measuring discomfort and symptoms (p = .023). The SLP examined 23 (77%) patients, finding functional voice problems in six (26%). The study showed that most globus patients felt their symptoms diminished without any treatment during four months. In some patients, coexisting voice problems may be associated with persistent globus.
- 17 September 2016
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 274 (2) , 931-937
Work-up of globus: assessing the benefits of neck ultrasound and videofluorography
Globus patients with normal ear, nose, and throat (ENT) status are a diagnostic challenge. The symptom may be long lasting and cause concern about malignancy, leading to possibly unnecessary further investigation. The aim of the study was to assess whether radiological examinations are useful in globus diagnostics, how often patients suffer from persistent globus, and whether globus patients with normal ENT status develop a malignancy during a follow-up. We reviewed medical records of all 76 globus patients referred to Helsinki University Hospital, Department of Otorhinolaryngology-Head and Neck Surgery in 2009. Patient history and findings in physical and radiological examinations were registered. A questionnaire concerning patients’ present pharyngeal symptoms was sent 3 and 6 years after their initial visit. Data from the Finnish Cancer Registry revealed whether patients developed malignancies within a 3-year follow-up. Based on medical records, neck ultrasound was performed for 37 (49 %) and videofluorography for 22 patients (29 %), with nonsignificant findings. After a 3- and 6-year follow-up, half patients indicated that they were asymptomatic or had fewer symptoms, whereas the rest had persistent symptoms. The Finnish Cancer Registry data confirmed that globus patients developed no head and neck malignancies during a 3-year follow-up. In the present study, neck ultrasound and videofluorography showed no additional benefit to evaluate the globus etiology in patients whose ENT status was normal. Half the globus patients suffered from persistent symptoms after a 3- and 6-year follow-up, indicating that globus may cause discomfort chronically. However, no patients developed malignancies during a 3-year follow-up.
- 17 September 2016
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 274 (2) , 931-937
Work-up of globus: assessing the benefits of neck ultrasound and videofluorography
Globus patients with normal ear, nose, and throat (ENT) status are a diagnostic challenge. The symptom may be long lasting and cause concern about malignancy, leading to possibly unnecessary further investigation. The aim of the study was to assess whether radiological examinations are useful in globus diagnostics, how often patients suffer from persistent globus, and whether globus patients with normal ENT status develop a malignancy during a follow-up. We reviewed medical records of all 76 globus patients referred to Helsinki University Hospital, Department of Otorhinolaryngology-Head and Neck Surgery in 2009. Patient history and findings in physical and radiological examinations were registered. A questionnaire concerning patients’ present pharyngeal symptoms was sent 3 and 6 years after their initial visit. Data from the Finnish Cancer Registry revealed whether patients developed malignancies within a 3-year follow-up. Based on medical records, neck ultrasound was performed for 37 (49 %) and videofluorography for 22 patients (29 %), with nonsignificant findings. After a 3- and 6-year follow-up, half patients indicated that they were asymptomatic or had fewer symptoms, whereas the rest had persistent symptoms. The Finnish Cancer Registry data confirmed that globus patients developed no head and neck malignancies during a 3-year follow-up. In the present study, neck ultrasound and videofluorography showed no additional benefit to evaluate the globus etiology in patients whose ENT status was normal. Half the globus patients suffered from persistent symptoms after a 3- and 6-year follow-up, indicating that globus may cause discomfort chronically. However, no patients developed malignancies during a 3-year follow-up.